{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:43:28Z","timestamp":1794264208585,"version":"4.9.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["82DZL001A4"],"award-info":[{"award-number":["82DZL001A4"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Extracellular DNA (e-DNA) and neutrophil extracellular traps (NETs) are linked to asthmatics airway inflammation. However, data demonstrating the characterization of airway inflammation associated with excessive e-DNA production and its impact on asthma outcomes are limited.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To characterize the airway inflammation associated with excessive e-DNA production and its association with asthma control, severe exacerbations and pulmonary function, particularly, air trapping and small airway dysfunction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We measured e-DNA concentrations in induced sputum from 134 asthma patients and 28 healthy controls. We studied the correlation of e-DNA concentrations with sputum neutrophils, eosinophils and macrophages and the fractional exhaled nitric oxide (FeNO). Lung function was evaluated using spirometry, body plethysmography, impulse oscillometry and inert gas multiple breath washout. We stratified patients with asthma into low-DNA and high-DNA to compare lung function impairments and asthma outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients with severe asthma had higher e-DNA concentration (54.2\u2009\u00b1\u200942.4\u00a0ng\/\u00b5l) than patients with mild-moderate asthma (41.0\u2009\u00b1\u200944.1\u00a0ng\/\u00b5l) or healthy controls (26.1\u2009\u00b1\u200916.5\u00a0ng\/\u00b5l), (all p values\u2009&lt;\u20090.05). E-DNA concentrations correlated directly with sputum neutrophils (R\u2009=\u20090.49, p\u2009&lt;\u20090.0001) and negatively with sputum macrophages (R\u2009= \u2212\u00a00.36, p\u2009&lt;\u20090.0001), but neither with sputum eosinophils (R\u2009=\u20090.10, p\u2009=\u20090.26), nor with FeNO (R\u2009= \u2212\u00a00.10, p\u2009=\u20090.22). We found that 29% of asthma patients (n\u2009=\u200939) had high e-DNA concentrations above the upper 95th percentile value in healthy controls (55.6\u00a0ng \/\u03bcl). High-DNA was associated with broad lung function impairments including: airflow obstruction of the large (FEV<jats:sub>1<\/jats:sub>) and small airways (FEF50%, FEF25\u201375), increased air trapping (RV, RV\/TLC), increased small airway resistance (R5-20, sReff), decreased lung elasticity (X5Hz) and increased ventilation heterogeneity (LCI), (all P values\u2009&lt;\u20090.05). We also found that high e-DNA was associated with nearly three-fold greater risk of severe exacerbations (OR 2\u00b793 [95% CI 1.2\u20137.5]; p\u2009=\u20090\u00b7012), worse asthma control test (p\u2009=\u20090.03), worse asthma control questionnaire scores (p\u2009=\u20090.01) and higher doses of inhaled corticosteroids (p\u2009=\u20090.026).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Increased production of extracellular DNA in the airway characterizes a subset of neutrophilic asthma patients who have broad lung function impairments, poor symptom control and increased risk of severe exacerbations.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12931-021-01759-z","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T11:09:23Z","timestamp":1622718563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Raised sputum extracellular DNA confers lung function impairment and poor symptom control in an exacerbation-susceptible phenotype of neutrophilic asthma"],"prefix":"10.1186","volume":"22","author":[{"given":"Mustafa","family":"Abdo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohib","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Goldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Marwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bahmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Kirsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Trinkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"von Mutius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus F.","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Watz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the ALLIANCE study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,3]]},"reference":[{"issue":"9537","key":"1759_CR1","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S0140-6736(06)69290-8","volume":"368","author":"SE Wenzel","year":"2006","unstructured":"Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368(9537):804\u201313.","journal-title":"Lancet"},{"issue":"6","key":"1759_CR2","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jaci.2013.10.011","volume":"133","author":"WC Moore","year":"2014","unstructured":"Moore WC, Hastie AT, Li X, Li H, Busse WW, Jarjour NN, et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol. 2014;133(6):1557-63.e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"5 Pt 1","key":"1759_CR3","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1164\/ajrccm.160.5.9806170","volume":"160","author":"A Jatakanon","year":"1999","unstructured":"Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1532\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1759_CR4","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0091-6749(95)70128-1","volume":"95","author":"JV Fahy","year":"1995","unstructured":"Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995;95(4):843\u201352.","journal-title":"J Allergy Clin Immunol"},{"issue":"9171","key":"1759_CR5","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/S0140-6736(99)01813-9","volume":"353","author":"ID Pavord","year":"1999","unstructured":"Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 1999;353(9171):2213\u20134.","journal-title":"Lancet"},{"issue":"9","key":"1759_CR6","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1164\/rccm.201810-1869OC","volume":"199","author":"ME Lachowicz-Scroggins","year":"2019","unstructured":"Lachowicz-Scroggins ME, Dunican EM, Charbit AR, Raymond W, Looney MR, Peters MC, et al. Extracellular DNA, neutrophil extracellular traps, and inflammasome activation in severe asthma. Am J Respir Crit Care Med. 2019;199(9):1076\u201385.","journal-title":"Am J Respir Crit Care Med"},{"key":"1759_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/all.14059","volume":"75","author":"V Granger","year":"2020","unstructured":"Granger V, Taill\u00e9 C, Roach D, Letuv\u00e9 S, Dupin C, Hamidi F, et al. Circulating neutrophil and eosinophil extracellular traps are markers of severe asthma. Allergy. 2020;75:699\u2013702.","journal-title":"Allergy"},{"issue":"5663","key":"1759_CR8","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532\u20135.","journal-title":"Science"},{"key":"1759_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fimmu.2019.00047","volume":"10","author":"M Uddin","year":"2019","unstructured":"Uddin M, Watz H, Malmgren A, Pedersen F. NETopathic inflammation in chronic obstructive pulmonary disease and severe asthma. Front Immunol. 2019;10:47.","journal-title":"Front Immunol"},{"key":"1759_CR10","doi-asserted-by":"publisher","first-page":"e32366","DOI":"10.1371\/journal.pone.0032366","volume":"7","author":"M Saffarzadeh","year":"2012","unstructured":"Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE. 2012;7:e32366.","journal-title":"PLoS ONE"},{"issue":"5","key":"1759_CR11","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.jaci.2010.12.1103","volume":"127","author":"R Dworski","year":"2011","unstructured":"Dworski R, Simon H-U, Hoskins A, Yousefi S. Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways. J Allergy Clin Immunol. 2011;127(5):1260\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1759_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12890-018-0705-6","volume":"18","author":"O Fuchs","year":"2018","unstructured":"Fuchs O, Bahmer T, Weckmann M, Dittrich A-M, Schaub B, R\u00f6sler B, et al. The all age asthma cohort (ALLIANCE)\u2014from early beginnings to chronic disease: a longitudinal cohort study. BMC Pulm Med. 2018;18(1):140.","journal-title":"BMC Pulm Med"},{"issue":"4","key":"1759_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.rmed.2012.12.006","volume":"107","author":"F Pedersen","year":"2013","unstructured":"Pedersen F, Marwitz S, Seehase S, Kirsten A-M, Zabel P, Vollmer E, et al. HOPE-preservation of paraffin-embedded sputum samples\u2014a new way of bioprofiling in COPD. Respir Med. 2013;107(4):587\u201395.","journal-title":"Respir Med"},{"issue":"10","key":"1759_CR14","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.rmed.2015.08.008","volume":"109","author":"F Pedersen","year":"2015","unstructured":"Pedersen F, Marwitz S, Holz O, Kirsten A, Bahmer T, Waschki B, et al. Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients. Respir Med. 2015;109(10):1360\u20132.","journal-title":"Respir Med"},{"issue":"2 Pt 1","key":"1759_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1164\/ajrccm.161.2.9903097","volume":"161","author":"J Belda","year":"2000","unstructured":"Belda J, Leigh R, Parameswaran K, O\u2019Byrne PM, Sears MR, Hargreave FE. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med. 2000;161(2 Pt 1):475\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1759_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343\u201373.","journal-title":"Eur Respir J"},{"issue":"2","key":"1759_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319\u201338.","journal-title":"Eur Respir J"},{"issue":"3","key":"1759_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1183\/09031936.05.00035005","volume":"26","author":"J Wanger","year":"2005","unstructured":"Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511\u201322.","journal-title":"Eur Respir J"},{"issue":"6","key":"1759_CR19","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1183\/09031936.03.00089403","volume":"22","author":"E Oostveen","year":"2003","unstructured":"Oostveen E, MacLeod D, Lorino H, Farr\u00e9 R, Hantos Z, Desager K, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22(6):1026\u201341.","journal-title":"Eur Respir J"},{"issue":"3","key":"1759_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1183\/09031936.00069712","volume":"41","author":"PD Robinson","year":"2013","unstructured":"Robinson PD, Latzin P, Verbanck S, Hall GL, Horsley A, Gappa M, et al. Consensus statement for inert gas washout measurement using multiple- and single-breath tests. Eur Respir J. 2013;41(3):507\u201322.","journal-title":"Eur Respir J"},{"issue":"1","key":"1759_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/path.4232","volume":"231","author":"JN Fullerton","year":"2013","unstructured":"Fullerton JN, O\u2019Brien AJ, Gilroy DW. Pathways mediating resolution of inflammation: when enough is too much. J Pathol. 2013;231(1):8\u201320.","journal-title":"J Pathol"},{"issue":"8","key":"1759_CR22","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1136\/thx.2009.120741","volume":"65","author":"M Uddin","year":"2010","unstructured":"Uddin M, Nong G, Ward J, Seumois G, Prince LR, Wilson SJ, et al. Prosurvival activity for airway neutrophils in severe asthma. Thorax. 2010;65(8):684\u20139.","journal-title":"Thorax"},{"issue":"1","key":"1759_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2222.2012.04075.x","volume":"43","author":"JL Simpson","year":"2013","unstructured":"Simpson JL, Gibson PG, Yang IA, Upham J, James A, Reynolds PN, et al. Impaired macrophage phagocytosis in non-eosinophilic asthma. Clin Exp Allergy. 2013;43(1):29\u201335.","journal-title":"Clin Exp Allergy"},{"key":"1759_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02590-2017","author":"M Gr\u00e9goire","year":"2018","unstructured":"Gr\u00e9goire M, Uhel F, Lesouhaitier M, Gacouin A, Guirriec M, Mourcin F, et al. Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS. Eur Respir J. 2018. https:\/\/doi.org\/10.1183\/13993003.02590-2017.","journal-title":"Eur Respir J"},{"issue":"3","key":"1759_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1124\/jpet.112.202879","volume":"345","author":"MJ Lapponi","year":"2013","unstructured":"Lapponi MJ, Carestia A, Landoni VI, Rivadeneyra L, Etulain J, Negrotto S, et al. Regulation of neutrophil extracellular trap formation by anti-inflammatory drugs. J Pharmacol Exp Ther. 2013;345(3):430\u20137.","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"1759_CR26","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.4049\/jimmunol.156.11.4422","volume":"156","author":"LC Meagher","year":"1996","unstructured":"Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol. 1996;156(11):4422\u20138.","journal-title":"J Immunol"},{"issue":"2","key":"1759_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.rmed.2004.06.007","volume":"99","author":"LT Nguyen","year":"2005","unstructured":"Nguyen LT, Lim S, Oates T, Chung KF. Increase in airway neutrophils after oral but not inhaled corticosteroid therapy in mild asthma. Respir Med. 2005;99(2):200\u20137.","journal-title":"Respir Med"},{"key":"1759_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12931-015-0221-7","volume":"16","author":"F Grabcanovic-Musija","year":"2015","unstructured":"Grabcanovic-Musija F, Obermayer A, Stoiber W, Krautgartner W-D, Steinbacher P, Winterberg N, et al. Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation. Respir Res. 2015;16:59.","journal-title":"Respir Res"},{"key":"1759_CR29","doi-asserted-by":"publisher","first-page":"106144","DOI":"10.1016\/j.rmed.2020.106144","volume":"172","author":"TC Piva","year":"2020","unstructured":"Piva TC, Luft C, Antunes KH, Marostica PJC, Pinto LA, Donadio MVF. Extracellular DNA in sputum is associated with pulmonary function and hospitalization in patients with cystic fibrosis. Respir Med. 2020;172:106144.","journal-title":"Respir Med."},{"issue":"17","key":"1759_CR30","doi-asserted-by":"publisher","first-page":"13276","DOI":"10.18632\/oncotarget.24022","volume":"9","author":"Y Zou","year":"2018","unstructured":"Zou Y, Chen X, Xiao J, Bo Zhou D, Xiao LuX, Li W, et al. Neutrophil extracellular traps promote lipopolysaccharide-induced airway inflammation and mucus hypersecretion in mice. Oncotarget. 2018;9(17):13276\u201386.","journal-title":"Oncotarget"},{"key":"1759_CR31","doi-asserted-by":"publisher","unstructured":"Linssen RS, Chai G, Ma J, Kummarapurugu AB, van Woensel JBM, Bem RA et al. Neutrophil extracellular traps increase airway mucus viscoelasticity and slow mucus particle transit. Am J Respir Cell Mol Biol. 2021;64(1):69\u201378. https:\/\/doi.org\/10.1165\/rcmb.2020-0168OC.","DOI":"10.1165\/rcmb.2020-0168OC"},{"key":"1759_CR32","doi-asserted-by":"publisher","first-page":"408935","DOI":"10.1155\/2015\/408935","volume":"2015","author":"V Marcos","year":"2015","unstructured":"Marcos V, Zhou-Suckow Z, \u00d6nderYildirim A, Bohla A, Hector A, Vitkov L, et al. Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction. Mediators Inflamm. 2015;2015:408935.","journal-title":"Mediators Inflamm"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-021-01759-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-021-01759-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-021-01759-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T13:10:33Z","timestamp":1699103433000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-021-01759-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1759"],"URL":"https:\/\/doi.org\/10.1186\/s12931-021-01759-z","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,3]]},"assertion":[{"value":"25 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is a part from the prospective longitudinal All Age Asthma Cohort (ALLIANCE). The study was approved by local ethics committee at Medical School Luebeck, Germany, and is registered at clinicaltrials.gov (pediatric arm: NCT02496468; adult arm: NCT02419274).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mustafa Abdo reports no conflict of interest. Mohib Uddin reports no conflict of interest. Torsten Goldmann reports no conflict of interest; Sebastian Marwitz reports no conflict of interest, Thomas Bahmer reports grants from BMBF: Unrestricted research grant for the German Center for Lung Research (DZL), during the conduct of the study; personal fees from AstraZeneca, personal fees from GlaxoSmithKline, personal fees from Novartis, and personal fees from Roche, outside the submitted work. Olaf Holz reports no conflict of interest; Anne-Marie Kirsten reports no conflict of interest. Frederik Trinkmann received travel support from Actelion, Berlin Chemie, Boehringer Ingelheim, Chiesi, Novartis, Mundipharma and TEVA as well as speaker or consultation fees from AstraZeneca, Berlin Chemie, Boehringer Ingelheim, Bristol-Myers Squibb, Chiesi, GlaxoSmithKline, Novartis and Roche, Sanofi aventis, all outside the submitted work. Erika von Mutius reports personal fees from Pharmaventures, personal fees from OM Pharma S. A., personal fees from Springer-Verlag GmbH, personal fees from Elsevier GmbH and Elsevier Ltd., personal fees from Peptinnovate Ltd., personal fees from Turun Yliopisto, personal fees from Tampereen Yliopisto, personal fees from Helsingin Yliopisto, personal fees from European Respiratory Society, personal fees from Deutsche Pharmazeutische Gesellschaft e. V., personal fees from Massachusetts Medical Society, personal fees from Chinese University of Hongkong, personal fees from European Commission, personal fees from B\u00f6hringer Ingelheim International GmbH, personal fees from Universiteit Utrecht, Faculteit Diergeneeskunde, personal fees from Universit\u00e4t Salzburg, personal fees from Georg Thieme Verlag, personal fees from Japanese Society of Pediatric Allergy and Clinical Immunology (JSPACI), outside the submitted work; In addition, Dr. von Mutius has a patent LU101064 - Barn dust extract for the prevention and treatment of diseases pending, a patent EP2361632: Specific environmental bacteria for the protection from and\/or the treatment of allergic, chronic inflammatory and\/or autoimmune disorders with royalties paid to ProtectImmun GmbH, a patent EP 1411977: Composition containing bacterial antigens used for the prophylaxis and the treatment of allergic diseases licensed to ProtectImmun GmbH, a patent number EP1637147: Stable dust extract for allergy protection licensed to ProtectImmun GmbH, and a patent EP 1964570: Pharmaceutical compound to protect against allergies and inflammatory diseases licensed to ProtectImmun GmbH. Matthias V. Kopp reports no conflict of interest, Gesine Hansen reports no conflict of interest. Klaus F. Rabe reports grants and personal fees from Boehringer Ingelheim and Astra Zeneca, personal fees from Novartis, Roche, Chiesi Pharmaceuticals, Regeneron, Sanofi and Berlin Chemie outside the submitted work. Henrik Watz reports no conflict of interest, Frauke Pedersen reports no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"167"}}